糖尿病,高血压和高脂血症患者的药物坚持的决定因素
Athanasios Chantzaras1, John Yfantopoulos2
1MBA Health Economics & Management School of Economics and Political Sciences, National and Kapodistrian University of Athens, 6 Themistokleous Street, 10678, Athens, Greece.
Hormones (Athens, Greece)
|February 19, 2025
概括
药物不服药在糖尿病,高血压和高脂血症中很普遍. 量身定制的策略至关重要,因为这些患者群体的坚持决定因素在这些患者群体之间有很大差异.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 药物不服药是治疗糖尿病,高血压和高脂血症等慢性疾病的一个重大挑战.
- 了解影响遵守的具体因素对于开发有效的干预措施至关重要.
研究的目的:
- 调查药物不服药的流行情况.
- 确定患有糖尿病,高血压和高脂血症的患者不坚持的决定因素.
主要方法:
- 这是一项多中心的横截面研究,涉及518名糖尿病患者,721名高血压患者和463名高脂血症患者.
- 使用重新填充和药物尺度 (ARMS) 评估的药物坚持.
- 多个线性回归分析了ARMS总结得分的预测因素.
主要成果:
- 低坚持率很高:糖尿病38.8%,高血压61.3%,高脂血症66.7%.
- 确定了许多不遵守的预测因素,包括人口统计,健康信仰,医生互动和疾病特异性因素.
- 在坚持和BMI/运动之间观察到曲线关系.
结论:
- 药物不服药在糖尿病,高血压和高脂血症队列中非常普遍.
- 干预策略必须是个性化的,承认每个患者群体中不遵守的独特决定因素.
相关概念视频
01:28Factors affecting Blood pressure
2.9K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
2.9K
01:15Diabetes: Management and Pharmacotherapy
229
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
229
01:28Drug Therapy
35
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
35
01:25Factors Influencing Drug Absorption: Disease States and Pharmacology
407
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
407
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
512
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
512
01:29Factors Affecting Protein-Drug Binding: Patient-Related Factors
34
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
34